# NHS England dataset restrictions

>Last modified: 07 Feb 2025

The specific terms set out in the table below are extracted from the data sharing agreement between UK LLC (University of Bristol) and NHS England. Researchers permitted to access these datasets **must adhere to these terms** when analysing the data and presenting and publishing their findings. UK LLC performs checks to ensure adherence and penalties will apply if these terms are breached.  

**Table 1** Specific data use terms extracted from the data sharing agreement between UK LLC and NHS England
|**NHS England dataset**|**Restrictions to use**|
|:--|:--|
|[**General Practice Extraction Service (GPES) Data for Pandemic Planning and Research (GDPPR)**](https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/primary_care_datasets/gdppr/gdppr)|1. Research must be related to **COVID-19**. For examples of research purposes acceptable to NHS England see the [**COVID-19 Public Health Directions 2020.**](https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/covid-19-public-health-directions-2020)<br>2. GDPPR data must **not** be used for any form of **performance management** of General Practices.|
|[**COVID-19 Second Generation Surveillance System (SGSS)**](https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid%20datasets/covidsgss/covidsgss)|1. Research must be related to **COVID-19**. For examples of research purposes acceptable to NHS England see the [**COVID-19 Public Health Directions 2020.**](https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/covid-19-public-health-directions-2020)|
|[**Enzyme-Linked Immunosorbent Assay (IELISA)**](https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid%20datasets/ielisa/ielisa)|1. Research must be related to **COVID-19**. For examples of research purposes acceptable to NHS England see the [**COVID-19 Public Health Directions 2020.**](https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/covid-19-public-health-directions-2020)|
|[**National Pathology Exchange (NPEX)**](https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid%20datasets/npex/npex)|1. Research must be related to **COVID-19**. For examples of research purposes acceptable to NHS England see the [**COVID-19 Public Health Directions 2020.**](https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/covid-19-public-health-directions-2020)|
|[**COVID-19 Hospitalisation in England Surveillance System (CHESS)**](https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid%20datasets/chess/chess)|1. Research must be related to **COVID-19**. For examples of research purposes acceptable to NHS England see the [**COVID-19 Public Health Directions 2020.**](https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/covid-19-public-health-directions-2020)|
|[**COVID-19 Vaccination Status (CVS)**](https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid%20datasets/cvs/cvs)|1. Research must be related to **COVID-19**. For examples of research purposes acceptable to NHS England see the [**COVID-19 Public Health Directions 2020.**](https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/covid-19-public-health-directions-2020)|
|[**COVID-19 Vaccination Adverse Reactions (CVAR)**](https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/covid%20datasets/cvar/cvar)|1. Research must be related to **COVID-19**. For examples of research purposes acceptable to NHS England see the [**COVID-19 Public Health Directions 2020.**](https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/covid-19-public-health-directions-2020)|
|[**Primary Care Medicines (PCM)**](https://guidebook.ukllc.ac.uk/docs/linked_health_data/nhs_england/other%20datasets/pcm/pcm)|1. Research must have a focus on the **safety and effectiveness of medicines** as specified by the [**NHSBSA Medicines Data Directions.**](https://digital.nhs.uk/about-nhs-digital/corporate-information-and-documents/directions-and-data-provision-notices/secretary-of-state-directions/nhs-business-services-authority-nhsbsa-medicines-data-directions-2019)|